Global Asthma Network Logo Global Asthma Network Global Asthma Network Logo

World Asthma Day 2018: Deaths preventable if reach of asthma medicines increased

Around the world an estimated 1,000 people a day die of asthma related conditions, with some 340 million affected by this common chronic disease In New Zealand more than 521,000 people are taking medicines for asthma - one in nine adults and one in seven children. It causes a death here every week. Read more

GAN Steering Group Meeting 2017

The GAN Steering Group held their annual meeting in Murcia, Spain, on 6 & 7 September 2017, where the main topic was analyses of data.Read more

UK research for African lung health partnered with GAN

The Liverpool School of Tropical Medicine has recently received two prestigious grants: MRC Global Challenges Research Fund (GCRF) for Lung Health in Africa across the Life Course led by Dr Kevin Mortimer and National Institute for Health Research (NIHR) Global Health Research Unit on Lung Health and Tuberculosis in Africa led by Professor Bertie Squire.Read more

Global Burden of Disease

The latest estimates from the Global Burden of Disease (GBD) study estimate that there were 3.6 million deaths from the two most common chronic respiratory diseases in 2015.Read more

GAN publication

Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma.Read more

Global Impact of Respiratory Disease

The second edition of the Global Impact of Respiratory Disease was recently published by the Forum of International Respiratory Societies, with a foreword from Nikolai Khaltaev.Read more

  • Global Asthma Report 2014

    The Global Asthma Report 2014 was officially launched at the 45th Union World Conference on Lung Health in Barcelona on 30 October 2014 and is available from
    read more

  • Closing the world data gaps for asthma is a key activity of the Global Asthma Network

    The Global Asthma Report 2014 was officially launched at the 45th Union World Conference on Lung Health in Barcelona on 30 October 2014 and is available from

  • Governments should commit to research, intervention, and monitoring to reduce the burden of asthma in the world

    Asthma is a public health priority as it is a chronic respiratory disease affecting 334 million people worldwide

  • Countries should monitor asthma hospital admissions in children and adults to identify trends in asthma over time

    Hospital admissions need to be monitored to identify trends in asthma over time and prevent epidemics

  • Avoidable asthma deaths are still occurring due to inappropriate management of asthma

    including over-reliance on reliever medication rather than preventer medication

  • Health professionals in all countries should regard frequent or severe recurrent wheezing in infancy as part of the spectrum of asthma

  • Controlled asthma imposes far less of an economic burden than non-controlled asthma

    The yearly costs of poorly managed asthma are 56 billion in the US alone

  • All countries should have effective policy action on known, remediable causes of asthma¬†such as parental smoking (for children) and occupational exposures¬†

  • All countries should have national strategies and action plans to improve asthma management and reduce costs

  • Asthma management guidelines are an essential part of successfully managing asthma and promoting the delivery of quality asthma care

  • All countries should have a list of essential medicines for asthma including both inhaled corticosteroids and a bronchodilator

  • All asthma inhalers procured, distributed, and sold in countries should meet international quality standards

  • Guaranteed access to quality-assured essential asthma medicines is vital to improving asthma outcomes

  • Low-income countries need appropriately trained health professionals and health services organised to manage asthma

  • Asthma is a serious burden in low- and middle-income countries

    Governments in low- and middle-income countries should make asthma a health priority

  • Asthma is an important NCD in all regions of the world, affecting people in non-affluent as well as affluent countries

    Governments should include asthma in all actions from WHO Global Action Plan for NCDs

Funding and development partners

The Global Asthma Network received major funding from The International Union Against Tuberculosis and Lung Disease (The Union) from 2012-2015. It is also generously supported by funding from the following organisations:

Asthma Australia
Woolcock Institute of Medical Research
Aix Marseille University
Center of Allergy & Immunology, Tbilisi
Riga Stradins University
New Zealand
The Asthma Foundation of New Zealand
Auckland Asthma Charitable Trust
Boehringer Ingelheim
University of Auckland
University of Murcia
Valencia University
Sultanate of Oman
The Oman Respiratory Society
United Kingdom
Liverpool School of Tropical Medicine
London School of Hygiene and Tropical Medicine
National Institute for Health Research
St Georges University of London
UK Medical Research Council